Susquehanna International Group, LLP Rigel Pharmaceuticals Inc Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 07, 2024	SELL	$1.12 - $1.57 $4,480 - $6,280	-4,000 Reduced 11.59%	30,500 $45,000
Q4 2023 Feb 14, 2024	SELL	$0.72 - $1.56 $12,168 - $26,364	-16,900 Reduced 32.88%	34,500 $50,000
Q3 2023 Nov 14, 2023	SELL	$1.07 - $1.39 $19,153 - $24,881	-17,900 Reduced 25.83%	51,400 $55,000
Q2 2023 Aug 11, 2023	BUY	$1.12 - $1.82 $39,312 - $63,882	35,100 Added 102.63%	69,300 $89,000
Q1 2023 May 16, 2023	BUY	$1.25 - $2.0 $42,750 - $68,400	34,200 New	34,200 $45,000
Q3 2022 Nov 14, 2022	SELL	$1.1 - $12.2 $4,730 - $52,460	-4,300 Reduced 15.99%	22,600 $27,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.